Stephen S. Yoder
2017
In 2017, Stephen S. Yoder earned a total compensation of $1.3M as Chief Executive Officer at Pieris Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $225,000 |
|---|---|
| Option Awards | $564,201 |
| Salary | $450,000 |
| Other | $10,800 |
| Total | $1,250,001 |
Yoder received $564.2K in option awards, accounting for 45% of the total pay in 2017.
Yoder also received $225K in bonus, $450K in salary and $10.8K in other compensation.
Rankings
In 2017, Stephen S. Yoder's compensation ranked 7,907th out of 14,666 executives tracked by ExecPay. In other words, Yoder earned more than 46.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,907 out of 14,666 | 46th |
Division Manufacturing | 2,966 out of 5,772 | 49th |
Major group Chemicals And Allied Products | 969 out of 2,075 | 53rd |
Industry group Drugs | 755 out of 1,731 | 56th |
Industry Pharmaceutical Preparations | 592 out of 1,333 | 56th |
Source: SEC filing on June 14, 2018.
Yoder's colleagues
We found three more compensation records of executives who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2017.